Unipolare Depression Langfassung - Versorgungsleitlinien.de

380. Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R,
Weinberger M. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a
randomized trial. JAMA 2001;286(23):2947-55.
381. Williams JW, Jr., Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J. A systematic review
of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern
Med 2000;132(9):743-56.
382. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective
serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a populationbased
cohort study. Arch Intern Med 2003;163(1):59-64.
383. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake
inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ
1999;319(7217):1106-9.
384. Gelenberg AJ. Bleeding with SSRIs. Biol Ther Psychiatry 2005;28.
385. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of
risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.
Arch Intern Med 2004;164(21):2367-70.
386. Movig KL, Janssen MW, de Waal MJ, Kabel PJ, Leufkens HG, Egberts AC. Relationship of
serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.
Arch Intern Med 2003;163(19):2354-8.
387. Stingl J, Schmidt LG. Blutungsneigung unter neueren Antidepressiva (SSRI). AVP
1999;(2):10.
388. Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E, Orwoll E, Bliziotes
MM. Association of low bone mineral density with selective serotonin reuptake inhibitor use by
older men. Arch Intern Med 2007;167(12):1246-51.
389. Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, Ensrud KE. Use of
antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
Arch Intern Med 2007;167(12):1240-5.
390. Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ). SSRI und Suizidalität?
(Kurzfassung). Dtsch Arztebl 2004;101(39):A-2642.
391. Healy D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
Psychother Psychosom 2003;72(2):71-9.
392. Beasley CM, Jr., Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH, Jr., Heiligenstein JH,
Thompson VL, Murphy DJ, Masica DN. Fluoxetine and suicide: a meta-analysis of controlled
trials of treatment for depression. BMJ 1991;303(6804):685-92.
393. Jenner PN. Paroxetine: an overview of dosage, tolerability, and safety. Int Clin
Psychopharmacol 1992;6 Suppl 4:69-80.
394. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in
comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol
1995;5(1):5-13.
395. Tollefson GD, Fawcett J, Winokur G, Beasley CM, Jr., Potvin JH, Faries DE, Rampey AH, Jr.,
Sayler ME. Evaluation of suicidality during pharmacologic treatment of mood and nonmood
disorders. Ann Clin Psychiatry 1993;5(4):209-24.
396. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other
antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160(4):790-2.
397. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995;310(6974):215-8.
398. Goder R, Friege L, Treskov V, Grohmann R, Aldenhoff JB. Association of paroxetine with
suicide attempt in obsessive-compulsive disorder. Pharmacopsychiatry 2000;33(3):116-7.
399. Müller-Oerlinghausen B, Berghöfer A. Antidepressants and suicidal risk. J Clin Psychiatry
1999;60 Suppl 2:94-9.
400. Donovan S, Kelleher MJ, Lambourn J, Foster R. The occurence of suicide following the
prescription of antidepressant drugs. Arch Suicide Res 1999;5:181-92.
© 2009 220